메뉴 건너뛰기
Rheumatology
Volumn 46, Issue 12, 2007, Pages 1863-1864
Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-α agents: The Newcastle (UK) experience [6]
Author keywords

[No Author keywords available]
Indexed keywords

TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
EID: 36448941210     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem252     Document Type: Letter
Times cited : (6)
References (8)
  • 1
    • 34447302542 scopus 로고    scopus 로고
    • Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: The Newcastle (UK) experience
    • Pratt A, Nicholl K, Kay L. Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: The Newcastle (UK) experience. Rheumatology 2007;46:1035-6.
    • (2007) Rheumatology , vol.46 , pp. 1035-1036
    • Pratt, A.1    Nicholl, K.2    Kay, L.3
  • 2
    • 0032885006 scopus 로고    scopus 로고
    • Evaluation of the tuberculin gamma interferon assay: Potential to replace the Mantoux skin test
    • Pottumarthy S, Morris AJ, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: Potential to replace the Mantoux skin test. J Clin Microbiol 1999;37:3229-32.
    • (1999) J Clin Microbiol , vol.37 , pp. 3229-3232
    • Pottumarthy, S.1    Morris, A.J.2    Harrison, A.C.3    Wells, V.C.4
  • 3
    • 36448938273 scopus 로고    scopus 로고
    • Food and Drug Administration, Center for Devices and Radiological Health. QuantiFERON®-TB - P010033 [Letter]. Rockville, MD: Food and Drug Administration, 2002. Available at http://www.fda.gov/cdrh/pdf/ P010033b.pdf.
    • Food and Drug Administration, Center for Devices and Radiological Health. QuantiFERON®-TB - P010033 [Letter]. Rockville, MD: Food and Drug Administration, 2002. Available at http://www.fda.gov/cdrh/pdf/ P010033b.pdf.
  • 4
    • 36448945916 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention, http://www.odc.gov/mmwr/ preview/mmwrhtml/rr5202a2.htm
  • 5
    • 25444517037 scopus 로고    scopus 로고
    • BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment
    • Ormerod LP, Milbum HJ, Gillespie J, Ledingham J, Rampton D. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005;60:800-5.
    • (2005) Thorax , vol.60 , pp. 800-805
    • Ormerod, L.P.1    Milbum, H.J.2    Gillespie, J.3    Ledingham, J.4    Rampton, D.5
  • 6
    • 33746554487 scopus 로고    scopus 로고
    • Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferongamma test
    • Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferongamma test. Respir Res 2006;7:56.
    • (2006) Respir Res , vol.7 , pp. 56
    • Brock, I.1    Ruhwald, M.2    Lundgren, B.3    Westh, H.4    Mathiesen, L.R.5    Ravn, P.6
  • 7
    • 34250873948 scopus 로고    scopus 로고
    • Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy
    • Lalvani A. Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy. Chest 2007;131:1898-906.
    • (2007) Chest , vol.131 , pp. 1898-1906
    • Lalvani, A.1
  • 8
    • 34247251473 scopus 로고    scopus 로고
    • Risk factors for positive tuberculin skin test in Guinea-Bissau
    • Gustafson P, Lisse I, Gomes V et al. Risk factors for positive tuberculin skin test in Guinea-Bissau. Epidemiology 2007;18:340-7.
    • (2007) Epidemiology , vol.18 , pp. 340-347
    • Gustafson, P.1    Lisse, I.2    Gomes, V.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.